Maisa N. Feghali, MD
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Maisa N. Feghali, MD sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Maisa N. Feghali, MD: 3 sponsored US clinical trials, 1 recruiting.
Maisa N. Feghali, MD sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pregnancy in Diabetes, with 1 trials.
Upper-quartile sponsor footprint
Maisa N. Feghali, MD sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
NCT05482789
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632
Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus
NCT03029702
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
Where Maisa N. Feghali, MD enrollment is open (later-stage tilt)
1 recruiting of 3 indexed (33% open); 1 completed (33%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Pregnancy in Diabetes (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Maisa N. Feghali, MD: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Maisa N. Feghali, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Maisa N. Feghali, MD page
3 registered trials is a research-attention snapshot, not an endorsement of Maisa N. Feghali, MD or any single study.
- 1 of Maisa N. Feghali, MD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pregnancy in Diabetes is the condition Maisa N. Feghali, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pregnancy in Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Maisa N. Feghali, MD pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.